Dealing in securities Mediclinic International Limited Incorporated in the Republic of South Africa Registration number: 1983/010725/06 ISIN: ZAE000074142 JSE share code: MDC NSX share code: MCI ("Mediclinic" or “the Company”) DEALINGS IN SECURITIES In compliance with the Listings Requirements of the JSE Limited, the following directors of Mediclinic or a major subsidiary of Mediclinic, as well as the company secretary of Mediclinic, elected to follow their rights to subscribe for new Mediclinic shares, as detailed below, pursuant to the rights issue by Mediclinic, as announced on SENS on 21 July 2015 and further detailed in the circular to shareholders dated 3 August 2015. In accordance with the salient dates relating to the rights issue by Mediclinic, the rights issue shares will be issued on or about Monday, 24 August 2015. The rights issue by Mediclinic is in respect of 111 111 111 shares made to shareholders in the ratio of 12.80145 new rights issue shares for every 100 shares held at the close of trade on Friday, 7 August 2015 at a price of R90.00 per rights offer share. Director : Dr E de la H Hertzog Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 9 143 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R822 870.00 Nature of interest : Direct beneficial Director : Dr E de la H Hertzog Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 610 209 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R54 918 810.00 Nature of interest : Indirect beneficial Director : Dr E de la H Hertzog Associate : Mrs E Hertzog (wife) Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 62 449 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R5 620 410.00 Nature of interest : Held by an associate Director : Mr DP Meintjes Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 19 305 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R1 737 450.00 Nature of interest : Direct beneficial Director : Meintjes Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 19 038 (in respect of share awards in terms of the forfeitable share plan) Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R1 713 420.00 Nature of interest : Direct beneficial Director : Mr CI Tingle Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 11 289 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R1 016 010.00 Nature of interest : Direct beneficial Director : Mr CI Tingle Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 10 877 (in respect of share awards in terms of the forfeitable share plan) Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R978 930.00 Nature of interest : Direct beneficial Director : Dr CA van der Merwe Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 4 843 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R435 870.00 Nature of interest : Direct beneficial Director : Dr CA van der Merwe Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 6 330 (in respect of share awards in terms of the forfeitable share plan) Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R569 700.00 Nature of interest : Direct beneficial Director : Mr KHS Pretorius Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 16 642 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R1 497 780.00 Nature of interest : Direct beneficial Company secretary : Mr GC Hattingh Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 18 562 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R1 670 580.00 Nature of interest : Indirect beneficial Company Secretary : Mr GC Hattingh Company : Mediclinic International Limited Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 5 668 (in respect of share awards in terms of the forfeitable share plan) Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R510 120.00 Nature of interest : Direct beneficial Director : Mr A J Joubert Company : Mediclinic Southern Africa (Pty) Ltd (a major subsidiary of Mediclinic International Limited) Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 6 578 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R592 020.00 Nature of interest : Direct beneficial Director : Mr WH Aucamp Company : Mediclinic Southern Africa (Pty) Ltd (a major subsidiary of Mediclinic International Limited) Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 5 121 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R460 890.00 Nature of interest : Direct beneficial Director : Dr B Valodia Company : Mediclinic Southern Africa (Pty) Ltd (a major subsidiary of Mediclinic International Limited) Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 1 280 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R115 200.00 Nature of interest : Direct beneficial Company secretary : Mrs TA Edwards Company : Mediclinic Southern Africa (Pty) Ltd (a major subsidiary of Mediclinic International Limited) Nature of transaction : Off-market purchase of shares in terms of the rights issue Number of securities : 76 Class of securities : Ordinary shares offered in terms of the rights issue Total value of transaction : R6 840.00 Nature of interest : Direct beneficial Clearance to deal was obtained for the above transactions. Stellenbosch 19 August 2015 Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa PO Box 456, Stellenbosch 7599, South Africa Tel +27 (0)21 809 6500 Fax +27 (0)21 886 4037 Ethics Line: 0800 005 316 Website: www.mediclinic.com JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited) NSX sponsor: Simonis Storm Securities (Pty) Ltd Date: 19/08/2015 12:35:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.